| Literature DB >> 28979116 |
Yvonne Jg Korpershoek1,2, Joyce C Bruins Slot1, Tanja W Effing3,4, Marieke J Schuurmans1,2, Jaap Ca Trappenburg1.
Abstract
BACKGROUND: Little is known about which self-management behaviors have the highest potential to influence exacerbation impact in COPD patients. We aimed to reach expert consensus on the most relevant set of self-management behaviors that can be targeted and influenced to maximize reduction of exacerbation impact.Entities:
Keywords: COPD; Delphi study; Delphi technique and behavior; exacerbation; self-care; self-management
Mesh:
Year: 2017 PMID: 28979116 PMCID: PMC5608232 DOI: 10.2147/COPD.S138867
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1Study design of the Delphi study.
Figure 2Conceptual model of patients’ fluctuations in symptoms during the course of COPD.
Inclusion and exclusion criteria of self-management behaviors
| Inclusion or exclusion | Criteria |
|---|---|
| Include in final list | Median score of 7–9 for at least 2 statements, including statement 1 |
| Include in next Delphi round | Each statement with an IQR >2. |
| Exclude | • 1 (or more) statement(s) with a median of 1–3 AND an IQR ≤2 for all 3 statements. |
| • 2 (or more) statements with a median of 4–6 AND an IQR ≤2 for all 3 statements. | |
| • Statement 1 with a median of 4–6 AND an IQR ≤2 for all 3 statements. |
Notes:
A median of 7–9 on statement 1 was required in all cases since statement 1 investigated the association between a self-management behavior and reduction of exacerbation impact and was considered to be most important. Median 1–3= not relevant/feasible; median 4–6= uncertain; median 7–9= relevant/feasible.
Abbreviation: IQR, interquartile range.
Demographic characteristics of the Delphi panel (n=19)*
| Characteristics | n (%) |
|---|---|
| Gender | |
| Male | 15 (79) |
| Age (years) | |
| 30–49 | 9 (47) |
| 50–69 | 9 (47) |
| >70 | 1 (5) |
| Experience in respiratory care focusing on COPD (years) | |
| 0–5 | 1 (5) |
| 6–15 | 7 (37) |
| 16–25 | 3 (16) |
| 26–35 | 5 (26) |
| >35 | 3 (16) |
| Area of focus | |
| Patient care | 1 (5) |
| Research | 5 (26) |
| Both patient care and research | 13 (68) |
| Country | |
| the Netherlands | 8 (42) |
| UK | 2 (11) |
| Belgium | 1 (5) |
| Canada | 1 (5) |
| USA | 4 (21) |
| Australia | 3 (16) |
| Discipline | |
| Pulmonology | 11 (58) |
| Primary care | 3 (16) |
| Nursing | 1 (5) |
| Physiotherapy | 1 (5) |
| Epidemiology | 3 (16) |
Note:
One expert of the panel was involved in this study by providing expert opinion on the process of the Delphi study.
Results of Delphi round 1 and 2
| Phase | Self-management behaviors rated in Delphi rounds | Behavior identified from (source) | Round 1 | Round 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Relevance | Improvement | Feasibility | Relevance | Improvement | Feasibility | |||||||||
| M | IQR | M | IQR | M | IQR | M | IQR | M | IQR | M | IQR | |||
| 1. Stable (low risk) | Adherence to pharmacotherapy (LABA/LAMA and/or ICS) | Literature | 8 | 3 | 8 | 1 | 7 | 2 | 8 | 0.75 | NA | NA | NA | NA |
| Influenza vaccination uptake | Literature | 7 | 1.25 | 6 | 2.25 | 7 | 3 | NA | NA | 6 | 2 | 7 | 0.75 | |
| Daily physical activity | Literature | 7 | 2.25 | 9 | 1 | 7 | 1.25 | 7 | 1.5 | NA | NA | NA | NA | |
| Avoiding viral or bacterial stimuli | Literature | 7 | 2 | 7 | 2.25 | 6.5 | 2 | NA | NA | 7 | 0.75 | NA | NA | |
| Managing exposure to air quality | Face validity | 7 | 2 | 6 | 1.5 | 5 | 1.25 | NA | NA | NA | NA | NA | NA | |
| Smoking cessation | Literature | 8 | 2 | 8 | 2.25 | 7 | 3 | NA | NA | 8 | 0 | 7 | 1 | |
| Managing exposure to indoor air quality | Delphi round 1 | NA | NA | NA | NA | NA | NA | 6 | 1.75 | 5 | 1.75 | 5.5 | 1 | |
| 2. Mild deterioration | Early detection of symptom deterioration | Face validity | 8 | 1.25 | 8 | 0.5 | 7.5 | 1 | NA | NA | NA | NA | NA | NA |
| Correct increase of SABA | Literature | 6 | 2 | 5.5 | 2.25 | 6 | 2.25 | NA | NA | 6 | 1 | 6 | 0.75 | |
| Performing breathing exercises | Literature | 5.5 | 2.25 | 7 | 3 | 6.5 | 2 | 5 | 1 | 7 | 0.75 | NA | NA | |
| Performing energy conservation techniques | Literature | 6 | 1.25 | 6 | 2 | 6 | 2.25 | NA | NA | NA | NA | 6 | 0.75 | |
| 3. Exacerbation | Early detection of an exacerbation | Literature | 9 | 1 | 8 | 2 | 7 | 1 | NA | NA | NA | NA | NA | NA |
| Prompt treatment with corticosteroids and/or AB (self-treatment) | Literature | 8.5 | 1 | 8 | 1.25 | 7 | 1.25 | NA | NA | NA | NA | NA | NA | |
| Prompt treatment with corticosteroids and/or AB (contacting HCP) | Literature | 8.5 | 1 | 8 | 1.5 | 8 | 2.25 | NA | NA | NA | NA | 8 | 0 | |
| Manage stress and anxiety | Literature | 7 | 1 | 7 | 0.5 | 6 | 2 | NA | NA | NA | NA | NA | NA | |
| Literature | 6 | 3.5 | NA | NA | NA | NA | 6 | 1 | NA | NA | NA | NA | ||
| Literature | 6.5 | 2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | ||
| Literature | 7 | 3 | NA | NA | NA | NA | 7 | 1.75 | NA | NA | NA | NA | ||
| Literature | 6 | 2.25 | NA | NA | NA | NA | 6 | 1 | NA | NA | NA | NA | ||
| 4. Recovery | Completing treatment with corticosteroids and/or AB | Face validity | 7 | 1.25 | 6.5 | 2.25 | 7 | 1.25 | NA | NA | 6.5 | 1 | NA | NA |
| Manage stress and anxiety (concerning current event) | Literature | 7 | 1.5 | 7 | 1.25 | 7 | 2.25 | NA | NA | NA | NA | 7 | 0.75 | |
| Adjusted exercise- and resistance training | Literature | 7 | 1.25 | 8 | 2 | 7 | 1.25 | NA | NA | NA | NA | NA | NA | |
| Literature | 8 | 1.5 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | ||
| Literature | 6.5 | 3 | NA | NA | NA | NA | 6 | 0.75 | NA | NA | NA | NA | ||
| Literature | 6 | 2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | ||
| Literature | 6 | 1.25 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | ||
| 5. Stable (at risk) | Increased awareness for recurring exacerbation | Literature | 8 | 2 | 8 | 2 | 7.5 | 1.25 | NA | NA | NA | NA | NA | NA |
| Early (re)start of pulmonary rehabilitation | Face validity | 8 | 2 | 8 | 2.25 | 7 | 2 | NA | NA | 8 | 0 | NA | NA | |
Notes:
Self-management behavior included in final list after round 1 or 2 based on median scores and consensus within the expert panel.
Self-management behavior excluded after round 1 or 2 based on median scores and consensus within the expert panel.
Relevance – The association of this behavior and reducing exacerbation impact (statement 1).
Improvement – The extent to whether there is room for improvement in this behavior (statement 2).
Feasibility – The feasibility to influence this behavior (statement 3). Scores are on a 9 point Likert scale (1= strongly disagree, 9= strongly agree); bold type indicates the returning self-management behaviors in which only statement 1 was rated and therefore scores on statements 2 and 3 are not applicable.
Abbreviations: NA, not applicable; M, median; IQR, interquartile range; AB, antibiotics; HCP, health care provider; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; ICS, inhaled corticosteroids; SABA, short-acting β2-agonist.
Final self-management behaviors per phase of the conceptual model
| Phase | Statement | Relevant and feasible self-management behaviors | Categories | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| 1. Stable phase (low risk) | ✓ | ✓ | Adherence to pharmacotherapy (LABA/LAMA and/or ICS) | Adherence to pharmacotherapy | |
| ✓ | ~ | ✓ | Influenza vaccination uptake | Influenza vaccination | |
| ✓ | ✓ | ✓ | Daily physical activity | Physical activity/exercise | |
| ✓ | ✓ | ~ | Avoiding viral or bacterial stimuli | Avoiding stimuli | |
| ✓ | ✓ | ✓ | Smoking cessation | Smoking cessation | |
| 2. Mild deterioration | ✓ | ✓ | ✓ | Early detection of symptom deterioration | Early detection of symptom deterioration |
| 3. Exacerbation (including onset) | ✓ | ✓ | ✓ | Early detection of an exacerbation | Early detection of symptom deterioration |
| ✓ | ✓ | ✓ | Prompt treatment corticosteroids and/or AB (self-treatment) | Medical treatment of exacerbations | |
| ✓ | ✓ | ✓ | Prompt treatment corticosteroids and/or AB (contact with HCP) | Medical treatment of exacerbations | |
| ✓ | ✓ | ~ | Manage stress and anxiety | Manage stress and anxiety | |
| ✓ | NA | NA | Physical activity/exercise | ||
| 4. Recovery phase | ✓ | ~ | ✓ | Completing treatment of antibiotics and/or corticosteroids | Medical treatment of exacerbations |
| ✓ | ✓ | ✓ | Manage stress and anxiety (concerning current event) | Manage stress and anxiety | |
| ✓ | ✓ | ✓ | Adjusted exercise- and resistance-training | Physical activity/exercise | |
| ✓ | NA | NA | Physical activity/exercise | ||
| 5. Stable phase (at risk) | ✓ | ✓ | ✓ | Increased awareness for recurring exacerbation | Awareness for recurrent exacerbations |
| ✓ | ✓ | ✓ | Early (re)start of pulmonary rehabilitation | Physical activity/exercise | |
Notes: Bold type indicates the returning self-management behaviors in which only statement 1 was rated. ✓ = Median of 7–9 for statement. ~ = Median of 4–6 for statement. 1= Relevance – The association of this behavior and reducing exacerbation impact (statement 1). 2= Improvement – The extent to whether there is room for improvement in this behavior (statement 2). 3= Feasibility – The feasibility to influence this behavior (statement 3).
Abbreviations: AB, antibiotics; HCP, health care provider; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; ICS, inhaled corticosteroids; NA, not applicable.
Qualitative results of Delphi round 1 and 2
| Phase | Results | Self-management behavior | Citations |
|---|---|---|---|
| 1. Stable (low risk) | Experts initially disagreed on the relevance of pharmacotherapy (LABA/LAMA and/or ICS). One expert stated that high level evidence is available, whereas other experts stated that ICS use is overrated in many COPD patients and that the role of pharmacotherapy is small and only relevant to a subgroup of patients. Furthermore, experts initially disagreed on the room for improvement regarding influenza vaccination uptake. Some experts considered vaccination uptake to be high, whereas others noted that room for improvement depends on region and country. Disagreement on the feasibility to influence vaccination uptake was observed since some experts believed that influenza vaccination is already heavily promoted and uptake is hard to influence. [C1] | Vaccination uptake | I think that vaccination uptake is harder to influence than other pharmacotherapy. People may have stronger opinions why to do/not to do it. [C1] |
| Managing exposure to air quality | I have my doubts. Patients do need to get out sometimes, and if there are prolonged periods of air pollution, I am not sure how to solve this problem. [C2] | ||
| Quitting/cutting down smoking | Smokers with COPD are a population that often have difficulty quitting and therefore will likely require more intensive interventions to influence smoking rates. [C3] | ||
| 2. Mild deterioration | Several comments focused on the relevance of correctly increasing SABA in several phases. Some experts considered SABA as obsolete and one expert believed it should not be stimulated at all. Moreover, the role of SABA was questioned regarding further symptom deterioration. [C4] | Correct increase of SABA | […] whereas the use of SABA will lead to symptom relief, it will not (directly) influence further deterioration of the exacerbation. [C4] |
| Performing breathing exercises | Little is known about the individual need for breathing exercises. It is certainly not for all patients. [C5] | ||
| Performing energy conservation techniques | Most patients will conserve energy to reduce their symptoms during early exacerbations as a natural behavior. [C6] | ||
| 3. Exacerbation | Experts directly agreed on the relevance of early detection of symptom deterioration and exacerbations in round 1. Experts believed that symptom diaries or symptom scoring with action plans can be supportive. Nevertheless, the complexity of this behavior was emphasized as well as the importance of personalized advice regarding this behavior by focusing on previously experienced symptoms with exacerbations. [C6 and 7] | Early detection of an exacerbation | Collaborative self-management aimed at the early detection of the exacerbation and prompt, appropriate treatment of that exacerbation is reasonable, but this is not easily achieved. [C6] |
| Daily physical activity | In my opinion, daily PA is important to prevent the vicious circle of breathlessness and to increase fitness and health (and thereby preventing exacerbations). [C8] | ||
| Self-treatment with corticosteroids and/or AB | I think that self-treatment is indicated for a select group of patients. Otherwise overtreatment is a potential risk. [C11] | ||
| 4. Recovery | Relaxation techniques were considered to be important to manage stress and anxiety at exacerbation onset. However, initially disagreement was observed in the feasibility to change this behavior during exacerbation recovery. One expert thought that stress may be challenging to overcome, while another expert believed that well-designed interventions can influence stress and anxiety. [C12] | Manage stress and anxiety | With good quality interventions/support stress and anxiety can be influenced; at least partly. [C12] |
| 5. Stable (at risk) | Early (re)start of pulmonary rehabilitation was considered to be relevant and feasible, although initially consensus on room for improvement was lacking and challenges towards feasibility to influence this behavior were reported. One expert specifically stated that there is substantial room for improvement in this behavior based on current patient performance, but this might be out of the scope of the patients own influence or health care provider’s influence. [C13] | Early (re)start of pulmonary rehabilitation | No this is health care providing politics. [C13] |
Abbreviations: LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; ICS, inhaled corticosteroids; SABA, short-acting β2-agonist; C, citation from expert; PA, physical activity; AB, antibiotics.